O1-19-2Histone Demethylase KDM4C Is a Novel Oncogene and Prognostic Biomarker for Prostate Cancer

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

O1-19-1Characterization of URST1 as a Biomarker and Therapeutic Target for Lung Cancer and Oral Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

Splice Variant PRKC-ζ-PrC Is a Novel Biomarker of Human Prostate Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Cell-Free DNA: A Novel Biomarker for Patients With Prostate Cancer?

The Open Prostate Cancer Journal
2010English

Neuropilin-2: Novel Biomarker and Therapeutic Target for Aggressive Prostate Cancer

2014English

Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer

Anticancer Research
MedicineCancer ResearchOncology
2020English

The Novel Prostate Cancer Antigen 3 (PCA3) Biomarker

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2010English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Decreased Expression of Chromodomain Helicase DNA-binding Protein 9 Is a Novel Independent Prognostic Biomarker for Colorectal Cancer

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy